Cargando…

Correction to: Parkinson’s disease-related Leucine-rich repeat kinase 2 modulates nuclear morphology and genomic stability in striatal projection neurons during aging

Detalles Bibliográficos
Autores principales:	Chen, Xi, Xie, Chengsong, Tian, Wotu, Sun, Lixin, Zheng, Wang, Hawes, Sarah, Chang, Lisa, Kung, Justin, Ding, Jinhui, Chen, Shengdi, Le, Weidong, Cai, Huaibin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076926/ https://www.ncbi.nlm.nih.gov/pubmed/32178708 http://dx.doi.org/10.1186/s13024-020-00371-x

Ejemplares similares

Parkinson’s disease-related Leucine-rich repeat kinase 2 modulates nuclear morphology and genomic stability in striatal projection neurons during aging
por: Chen, Xi, et al.
Publicado: (2020)

ALDH1A1 regulates postsynaptic μ–opioid receptor expression in dorsal striatal projection neurons and mitigates dyskinesia through transsynaptic retinoic acid signaling
por: Pan, Jing, et al.
Publicado: (2019)

Longitudinal Metabolomics Profiling of Parkinson’s Disease-Related α-Synuclein A53T Transgenic Mice
por: Chen, Xi, et al.
Publicado: (2015)

Endogenous Leucine-Rich Repeat Kinase 2 Slows Synaptic Vesicle Recycling in Striatal Neurons
por: Maas, James W. Jr., et al.
Publicado: (2017)

Leucine-Rich Repeat Kinase 2 (Lrrk2) Deficiency Diminishes the Development of Experimental Autoimmune Uveitis (EAU) and the Adaptive Immune Response
por: Wandu, Wambui S., et al.
Publicado: (2015)

Parkinson's Disease: Leucine-Rich Repeat Kinase 2 and Autophagy, Intimate Enemies
por: Bravo-San Pedro, José M., et al.
Publicado: (2012)

Leucine-rich repeat kinase 2 mutations and Parkinson’s disease: three questions
por: Greggio, Elisa, et al.
Publicado: (2009)

Leucine-Rich Repeats and Transmembrane Domain 2 Controls Protein Sorting in the Striatal Projection System and Its Deficiency Causes Disturbances in Motor Responses and Monoamine Dynamics
por: Ichise, Misato, et al.
Publicado: (2022)

Leucine-Rich Repeat Kinase 2-Linked Parkinson’s Disease: Clinical and Molecular Findings
por: Kumari, Udhaya, et al.
Publicado: (2010)

The Double-Faceted Role of Leucine-Rich Repeat Kinase 2 in the Immunopathogenesis of Parkinson’s Disease
por: Zhang, Mengfei, et al.
Publicado: (2022)

Leucine-rich repeat kinase 2 and alpha-synuclein: intersecting pathways in the pathogenesis of Parkinson's disease?
por: Greggio, Elisa, et al.
Publicado: (2011)

Identical Twins with Leucine Rich Repeat Kinase Type 2 Mutations Discordant for Parkinson's Disease
por: Xiromerisiou, Georgia, et al.
Publicado: (2012)

Function and dysfunction of leucine-rich repeat kinase 2 (LRRK2): Parkinson’s disease and beyond
por: Bae, Jae Ryul, et al.
Publicado: (2015)

Loss of leucine-rich repeat kinase 2 causes age-dependent bi-phasic alterations of the autophagy pathway
por: Tong, Youren, et al.
Publicado: (2012)

Neurotransmitters, Cell Types, and Circuit Mechanisms of Motor Skill Learning and Clinical Applications
por: Tian, Wotu, et al.
Publicado: (2021)

Editorial: The Physiology and Pharmacology of Leucine-rich Repeat GPCRs
por: Arey, Brian J., et al.
Publicado: (2016)

Leucine Rich Repeat Kinase 2 and Innate Immunity
por: Ahmadi Rastegar, Diba, et al.
Publicado: (2020)

Leucine-rich repeat kinase 2 at a glance
por: Zhu, Christiane, et al.
Publicado: (2023)

Structure-Aware Annotation of Leucine-rich Repeat Domains
por: Xu, Boyan, et al.
Publicado: (2023)

Deficiency in endocannabinoid synthase DAGLB contributes to early onset Parkinsonism and murine nigral dopaminergic neuron dysfunction
por: Liu, Zhenhua, et al.
Publicado: (2022)

Substantia nigra hyperechogenicity in Parkinson disease patients with leucine-rich repeat kinase 2 variants in the Chinese Han population
por: Li, Kai, et al.
Publicado: (2020)

Advances in elucidating the function of leucine-rich repeat protein kinase-2 in normal cells and Parkinson's disease
por: Taylor, Matthew, et al.
Publicado: (2020)

Reversible Bilateral Striatal Hypermetabolism in a Patient with Leucine-Rich Glioma Inactivated-1 Encephalitis
por: Takkar, Aastha, et al.
Publicado: (2016)

Topological Analysis of Small Leucine-Rich Repeat Proteoglycan Nyctalopin
por: Bojang, Pasano, et al.
Publicado: (2012)

An extracellular network of Arabidopsis leucine-rich repeat receptor kinases
por: Smakowska-Luzan, Elwira, et al.
Publicado: (2018)

From structure to ætiology: a new window on the biology of leucine-rich repeat kinase 2 and Parkinson's disease
por: Herbst, Susanne, et al.
Publicado: (2021)

Colonic Leucine-Rich Repeat Kinase 2 Expression Is Increased and Associated With Disease Severity in Patients With Parkinson’s Disease
por: Liao, Peng-Hsiang, et al.
Publicado: (2022)

Generation of fourteen isogenic cell lines for Parkinson’s disease-associated leucine-rich repeat kinase (LRRK2)
por: Beylina, Aleksandra, et al.
Publicado: (2021)

Effect of a Leucine-rich Repeat Kinase 2 Variant on Motor and Non-motor Symptoms in Chinese Parkinson’s Disease Patients
por: Sun, Qian, et al.
Publicado: (2016)

Leucine‐rich repeat kinase 2 (LRRK2) inhibitors differentially modulate glutamate release and Serine935 LRRK2 phosphorylation in striatal and cerebrocortical synaptosomes
por: Mercatelli, Daniela, et al.
Publicado: (2019)

Effect of dual-task interference on the hand flexibility of patients with Parkinson’s disease carrying the leucine-rich repeat kinase 2 gene mutation
por: ZHOU, GUANGAN, et al.
Publicado: (2013)

Leucine-Rich repeat receptor kinases are sporadically distributed in eukaryotic genomes
por: Diévart, Anne, et al.
Publicado: (2011)

Leucine-Rich Repeat (LRR) Domains Containing Intervening Motifs in Plants
por: Matsushima, Norio, et al.
Publicado: (2012)

Assembly of Neuronal Connectivity by Neurotrophic Factors and Leucine-Rich Repeat Proteins
por: Ledda, Fernanda, et al.
Publicado: (2016)

Role and mechanism of action of leucine-rich repeat kinase 1 in bone
por: Xing, Weirong R, et al.
Publicado: (2017)

Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4
por: Russo, Isabella, et al.
Publicado: (2018)

Connectivity and Functionality of the Globus Pallidus Externa Under Normal Conditions and Parkinson's Disease
por: Dong, Jie, et al.
Publicado: (2021)

Inhibitors of Leucine Rich Repeat Kinase 2 (LRRK2) Protect Against LRRK2-Models of Parkinson’s Disease
por: Lee, Byoung Dae, et al.
Publicado: (2010)

WHOPPA Enables Parallel Assessment of Leucine-Rich Repeat Kinase 2 and Glucocerebrosidase Enzymatic Activity in Parkinson’s Disease Monocytes
por: Wallings, Rebecca L., et al.
Publicado: (2022)

Ganoderic Acid A targeting leucine‐rich repeat kinase 2 involved in Parkinson's disease–A computational study
por: Ahmad, Faizan
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_crm6sp8d0ous4m0fg63vv7kq5b